fungal ergosterol biosynthesis inhibitors (Pharmacia)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namefungal ergosterol biosynthesis inhibitors (Pharmacia)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene monooxygenase inhibitorsLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylaseSqualene monooxygenase
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia Corp
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A